UV Infection Control Devices Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Type (Mobile, Stationary), By End-User (Hospitals & Clinics, Pharmaceutical & Life science Companies), By Application (Surface Disinfection and Water Treatment), And By Geography - Forecasts From 2022 To 2027

UV Infection Control Devices Market Size:

The UV Infection Control Devices Market is expected to grow from USD 602.910 million in 2025 to USD 824.904 million in 2030, at a CAGR of 6.47%.

UV Infection Control Devices Market Trends:

A rise in the ageing demographics and a surge in chronic conditions amongst the global population, together with increased turnover of hospital rooms, has necessitated the global healthcare sector to equip itself with a range of infection control products. A notable number of people who receive healthcare are susceptible to contracting a healthcare-associated infection, which is monikered as nosocomial infections World Health Organization (WHO). This necessitates various healthcare establishments to increase their investment in infection control devices, out of which one noteworthy mention is UV infection control devices.

• The importance of tackling nosocomial infections has been so strongly felt that the integration of UV lights with products that are ubiquitously used is considered the optimum means of controlling and, after that, managing such diseases.

To this end, it should be noted that Spectralink, a leader in mobile enterprise solutions and Advanced Ultra-Violet Systems (AUVS), announced the approval of the AUVS UV Box for use with Spectralink Versity mobile phones. When used with the Spectralink Versity enterprise smartphone, the UV Box provides a unique infection control system to protect patients and staff from pathogens, thereby reducing hospital-acquired Infections (HAI) and consequently supporting healthcare infection prevention protocols. UV germicidal enclosures are generally employed as an additional safeguard against HAI in a medical environment. Christened initially as AUVS KR615, the device has widely become known as the UV Box. It is intended to close the gap in hospitals' infection prevention protocols working continuously between terminal cleanings and providing a better option than wipes. Despite its fame for destroying bacteria, ultraviolet light is notorious for damaging plastic and other materials. Spectralink Labs conducted extensive testing to determine the durability of the devices when exposed to UV rays under typical medical conditions before approving the use of UV enclosures for the disinfection of its Versity smartphones. This suggests the length to which players are willing to strive for a better product.

UV Infection Control Devices Market Growth Drivers:

• The other aspect that is poised to drive the growth of the market is the food and beverage segment.

This is a sector where it is a business imperative to prevent any cross-contamination and simultaneously preserve the flavor of raw materials and that of the ingredients, which becomes a daunting task when liquid disinfectants are used. Thus, another noteworthy development to this end is the world's first and only adoption of a UV infection control device by The Westin Houston Medical Centre by utilizing LightStrike™ Germ-Zapping Robots™ and contributing to the efforts of keeping the coronavirus away by sanitizing and disinfecting its guest rooms and common areas. Provided by San Antonio-based Xenex Disinfection Services, this room disinfection technology has been proven to quickly destroy viruses, bacteria, and fungi using intense pulsed xenon ultraviolet (UV) light. Intense germicidal UV light is used by The LightStrike robot to quickly destroy microscopic bacteria and viruses that may be missed during the manual cleaning process.

UV Infection Control Devices Market Geographical Outlook:

• Besides, the APAC and MEA region is witnessing a growing influx of medical tourists.

 Additionally, countries like India and the United Arab Emirates are endeavouring in the fuller utilization of resources available along with coming up with policies that will be conducive to the growth of medical tourism which is poised to drive the UV infection control market during the forecast period. Medical tourism or medical travel, health tourism, or global healthcare is a consumer-driven sector; the services are distinctively sought by patients who seek elective procedures as well as complex and sophisticated operational procedures like cardiac surgery, cosmetic surgery, joint replacements, and dental surgery. Thus, the Government of India has enabled triple entry for e-Medical visas and e-Medical Attendant Visas. An extension may be granted for up to 6 months on a case-to-case basis discerned by the Foreigners Regional Registration Officer (FRRO)/ Foreigners Registration Officer (FRO) concerned. Further, as of 2018, the estimated foreign exchange earnings from tourism were US $25.8 billion [Source: Ministry of Tourism, Government of India]. Further, the total number of tourist arrivals was 1403 million, with 1448 US$ billion accounted for international tourism receipts. Additionally, The Ministry of Tourism provides financial assistance under the Market Development Assistance Scheme (MDA) to approved wellness centres, i.e., representatives of wellness centres accredited by the National Accreditation Board of Hospitals (NABH) or the State Governments to woo tourists.

Considering the growth of medical tourism, thus the influx of patients from foreign countries, the need for establishments providing food and beverage as well as accommodations, and the need for new healthcare points as well as legacy healthcare providers to observe and adhere to strict infection prevention measures have emerged as paramount importance. Therefore, the demand for the UV infection control devices set in motion by both these symbiotic sectors (healthcare and tourism) is projected to galvanize the UV infection control market at both local and global levels to unprecedented heights during the forecast period.

Segmentation

• By Type
  • Mobile
  • Stationary
  • Others
• By End-User
  • Hospitals & Clinics
  • Pharmaceutical & Life Science Companies
• By Light Source
  • Ultraviolet-C (UVC)
  • Ultraviolet-A (UVA)
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Thailand
    • South Korea
    • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. UV INFECTION CONTROL DEVICES MARKET BY TYPE

5.1. Introduction

5.2. Mobile 

5.3. Stationary

5.4. Others

6. UV INFECTION CONTROL DEVICES MARKET BY END-USER 

6.1. Introduction

6.2. Hospitals & Clinics

6.3. Pharmaceutical & Life Science Companies

7. UV INFECTION CONTROL DEVICES MARKET BY LIGHT SOURCE

7.1. Introduction

7.2. Ultraviolet-C (UVC)

7.3. Ultraviolet-A (UVA)

8. UV INFECTION CONTROL DEVICES MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Australia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. American Ultraviolet, Inc. 

10.2. Atlantic Ultraviolet Corporation 

10.3. AquiSense Technologies 

10.4. Blue Ocean Robotics 

10.5. Crystal IS 

10.6. Halma PLC 

10.7. Kuraray Co., Ltd. 

10.8. R-Zero Systems, Inc. 

10.9. Seal Shield, LLC 

10.10. STERIS plc. 

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

American Ultraviolet, Inc.

Atlantic Ultraviolet Corporation

AquiSense Technologies

Blue Ocean Robotics

Crystal IS

Halma PLC

Kuraray Co., Ltd.

R-Zero Systems, Inc.

Seal Shield, LLC

STERIS plc

Sorry, the research methodology content could not be loaded.